News & Developments

ViewView
Press Releases

GSK Stockmann welcomes renowned M&A expert Dr Nina Leonard to its Corporate practice

Starting on 3 July 2026, Nina Leonard will be joining GSK Stockmann, bringing valuable expertise in the data centre, battery storage and life sciences/pharmaceuticals sectors. In line with its strategy to expand its Corporate practice, GSK Stockmann has appointed Nina Leonard, a certified specialist in commercial and company law, as a new Equity Partner at the firm’s Munich office, effective from 3 July 2026. She joins the firm from Addleshaw Goddard, where her work focused on M&A and corporate law. Nina Leonard has over 24 years of experience in M&A advisory and specialises in complex, cross-border transactions. She has particular expertise in the data centre, battery storage, digital infrastructure and technology sectors. Her other areas of focus are the energy and life sciences/pharmaceuticals sectors – both areas in which GSK Stockmann is looking to expand strategically. Her expertise also extends to joint ventures and conflict and stakeholder management, particularly in the context of shareholder and post-M&A disputes. Alongside her legal expertise, Nina Leonard brings an entrepreneurial mindset and a wealth of experience in expanding law firms. For example, she successfully helped lead an international law firm’s entry into the German market as a founding partner, demonstrating her ability to cultivate lasting client relationships and teams. Her international background, including stints in London, Chicago and Beijing, as well as her many years of experience working with a British commercial law firm, makes her an ideal liaison for GSK Stockmann’s London office. Nina Leonard also has an outstanding academic track record, having co-edited and co-authored the leading commentary on the German Transformation Act (Semler/Stengel/Leonard, UmwG, currently in its sixth edition, C.H. Beck 2025) and published numerous academic articles on commercial and company law. Nina Leonard’s appointment is the latest in a series of strategic lateral hires at GSK Stockmann over the past two years, the most recent being Per Meyerdierks (data protection and technology), Dr Simon Spangler (antitrust) and Dr Bernd Graßl (stock corporation and capital markets law, corporate litigation and dispute resolution). Dr Katy Ritzmann, Head of Corporate at GSK Stockmann, comments: “Nina Leonard combines first-class M&A expertise with in-depth industry knowledge in key growth sectors, which complements the expertise of our colleagues working on projects in these areas perfectly. At the same time, her international network is a real asset for our cross-border advisory services. We are delighted to have her on board.” Nina Leonard adds: “GSK Stockmann combines an entrepreneurial approach with outstanding legal advice across all the practice areas relevant to my work. This creates an ideal environment for providing clients with strategic support. I am very much looking forward to building on these strengths together with the team.” ### Press contact: GSK STOCKMANN Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de/en
GSK Stockmann - July 9 2026
Press Releases

Dentons Luxembourg invests in its talent and strengthens its banking, finance and corporate law practices.

Luxembourg, Monday 1st June 2026 – Dentons Luxembourg announces the promotion of Olivier Lesage to Partner and David Paiva to Managing Counsel, marking a new milestone in the international law firm’s development in the Luxembourg market. These promotions strengthen the office’s ability to support its clients in complex and multi-jurisdictional transactions. With fifteen years’ experience at Dentons, Olivier Lesage has been promoted to Partner in the Banking and Finance department. The department now has two Partners, with Olivier joining Stéphane Hadet, who has led the department for over twenty-five years. He advises corporate groups, financial institutions and investment funds on a wide range of transactions in Luxembourg and internationally, particularly in relation to restructurings, refinancing and leveraged finance. Olivier has extensive experience in banking and finance, including fund, real estate and asset financing, pre- and post-acquisition restructurings and reorganizations, as well as Luxembourg and European regulatory matters relating to the financial market. Stéphane Hadet comments: “Olivier has been a driving force behind the development of our Banking and Finance department for over fifteen years. This promotion recognizes not only the work he has done for our clients, but also his active role in training and developing the Luxembourg team.” In the Corporate and M&A department, David Paiva has been promoted to Managing Counsel, a role in which he supports the lead partner, Namik Ramić, with whom he has worked for over ten years. David specializes in corporate law, mergers and acquisitions, private equity, joint ventures, and related structuring and financing. He regularly advises international groups and private equity funds on their acquisitions and other structured transactions, as well as on the implementation of incentive schemes for management teams. He also advises on the structuring of vehicles and provides governance advice to family offices and high-net-worth private clients. Both lawyers are recognized for their strategic advice to major Luxembourg and international groups. Martine Gerber-Lemaire, Managing Partner of Dentons Luxembourg, said: “These promotions mark a new stage in Dentons’ development in the Luxembourg market. They come at a time of strong activity in real estate financing, fund financing, cross-border structuring and M&A transactions. They also reflect our ongoing commitment to the professional development of our talent and to creating a positive working environment where everyone can advance their career.” About Dentons Redefining possibilities. Together, everywhere. Dentons, the world’s largest international law firm, tackles every challenge and seizes every opportunity thanks to the talent of its 12,500 professionals working in over 85 countries. For more information, visit www.dentons.com Contact : Cédric Delahaye Head of Marketing, BD and Communication - Dentons Luxembourg D +352 46 83 83 312 | M +352 621 26 53 99 | [email protected]
Dentons - May 29 2026
Press Releases

GSK Stockmann advises on the sale of three life science properties in Heidelberg Technology Park

GSK Stockmann advised Technologiepark Heidelberg II GmbH & Co. KG, a subsidiary of Sparkasse Heidelberg, on the sale of three research and laboratory properties to GalCap Europe. The approximately 13,800 square metres of rental space are located in the “Im Neuenheimer Feld” technology park in Heidelberg. A GSK Stockmann team led by partner Dr Martin Prothmann provided Technologiepark Heidelberg II GmbH & Co. KG, a subsidiary of savings bank Sparkasse Heidelberg, with comprehensive advice on the sale. The Heidelberg Technology Park is located in the immediate vicinity of the University Hospital Heidelberg and the German Cancer Research Centre (DKFZ), placing it at the heart of one of Europe’s foremost life science clusters. The properties are fully let to companies and research institutions from the biotechnology, pharmaceutical and diagnostics sectors. The site is one of Germany’s central life science hubs, fostering close collaboration between university research, clinical applications and private companies. For the buyer, GalCap Europe, the transaction marks its entry into the German life science real estate market and the expansion of its portfolio, which currently comprises four properties in Austria with a market value of around EUR 100 million. Based in Vienna, GalCap Europe is a real estate asset and investment manager focusing on Austria and Central Europe. Advisers of the seller at GSK Stockmann: Dr Martin Prothmann (lead, Real Estate Transactions & Investments), Jakob Haddad (Real Estate Transactions & Investments), Pascal Franke (Real Estate Transactions & Investments), Stephan Wachsmuth (Tax) ### Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. More about us: www.gsk.de
GSK Stockmann - May 24 2026
Press Releases

GSK Stockmann advises Deka Immobilien on a long-term lease with E.ON in Munich

GSK Stockmann provided Deka Immobilien with comprehensive advice on the leasing of approximately 21,300 square metres of office space in the “An den Brücken” property at Landsberger Strasse 84-90 in Munich to the E.ON Group. The lease was signed in February 2026, and the tenant will be able to move into the first section of the rented space from January 2027. Following the conclusion of this deal, the approximately 23,000 sqm of office space available in the six-storey building is once again fully let. For GSK Stockmann, this transaction is part of a long history of advising Deka in connection with the “An den Brücken” property. The firm originally advised Deka Immobilien on the purchase of the building back in 2014 and has provided ongoing asset management advice for the property ever since, including providing support with lease agreements and settling the previous tenancy with the FTI Group. “We are delighted to have supported Deka Immobilien in the successful conclusion of this lease. The fact that we have been entrusted with supporting the property from its initial acquisition through ongoing asset management to this significant lease agreement is a testament to the confidence that our clients have in our comprehensive real estate expertise. I would like to thank my team, Katharina Groche (Local Partner) and Bianca Luppert (Associate), who provided the lion’s share of the advice in this case,” says Monique Franke, Partner for Real Estate Investments & Asset Management at GSK Stockmann. Advisers of Deka Immobilien at GSK Stockmann: Monique Franke and Katharina Groche (both lead), Bianca Luppert (all Real Estate Investments & Asset Management) [caption id="attachment_56686" align="alignnone" width="300"] GSK München[/caption]   ### Contact: GSK STOCKMANN Monique Franke Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174 - 661 F +49 89 288174-44 [email protected] Press contact: GSK STOCKMANN Christina Holl Karl-Scharnagl-Ring 8 80539 Munich T +49 89 288174-275 F +49 89 288 174-44 [email protected] GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind:  Your perspective. More about us: www.gsk.de
GSK Stockmann - May 24 2026